The Daily Buyout

Thursday, November 12, 2026

The Daily Buyout

22 deals · ~$6.1B in deal value

Illustration for the top deal in this edition

Banks set today's pace: Hancock Whitney is buying Trustmark, and a North Dakota lender is crossing into Texas. Samsung Fire & Marine is taking full control of a Lloyd's underwriter, and AstraZeneca has quietly bought a vaccine partner. Mid-market buyers stayed busy across aerospace, environmental services, HR and car dealerships.

Top deal of the day

Hancock Whitney agrees to acquire Trustmark

~$3.2BreportedStrategic acquisitionFinancial Services

Hancock Whitney Corporation has agreed to acquire Trustmark Corporation, according to an announcement datelined Gulfport, Mississippi. The release made available does not disclose the price, structure or expected timing, so the deal's size remains unknown for now.

Why it matters: A deal between two established regional bank holding companies extends this year's run of bank consolidation.

Good deal?

Get this in your inbox every morning

The day's biggest deals in five minutes. Free, with no paywalled links.

Free · Unsubscribe anytime

2
~$2.2BreportedStrategic acquisitionFinancial Services

Samsung Fire & Marine moves to take full control of Lloyd's insurer Canopius

Samsung Fire & Marine Insurance plans to acquire the remaining stake in Canopius Group, a major Lloyd's and specialty underwriter, under a share purchase agreement with a global private equity firm announced November 10. AM Best said Samsung Fire's A++ financial strength rating is unchanged after the announcement. Terms were not disclosed in the available text.

4
BRL 332M salesStrategic acquisitionIndustrials & Manufacturing

ASSA ABLOY buys Brazilian door-systems maker Rometal

ASSA ABLOY has agreed to acquire Rometal, a manufacturer of aluminum interior door systems, cabinet doors, frames and pullers based in Veranópolis, Brazil, with about 500 employees. Rometal's 2025 sales were about BRL 332 million (roughly SEK 580 million) with a strong EBIT margin. Terms were not disclosed, and the deal is expected to close in the fourth quarter.

5
UndisclosedStrategic acquisitionHealthcare & Life SciencesCompleted

AstraZeneca acquires vaccine partner Omniose

AstraZeneca has acquired Omniose, a vaccine startup and its development partner since a January 2024 alliance. Terms were not disclosed. The deal gives AstraZeneca Omniose's bioconjugation technology, a more efficient way to make conjugate vaccines, which it plans to use for shots against serious bacterial infections.

Other deals this day15 more

Get tomorrow's edition in your inbox

Free · Unsubscribe anytime